STOCK TITAN

Ionis to present at upcoming investor conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Ionis Pharmaceuticals, Inc. will participate in fireside chats at several investor conferences in November and December 2023. The conferences include Guggenheim 5th Annual Inflammation, Neurology, & Immunology Conference, Stifel 2023 Healthcare Conference, Piper Sandler 35th Annual Healthcare Conference 2023, and BMO 2023 Growth & ESG Conference. The presentations will be webcasted live on the Ionis website and replays will be available within 48 hours.
Positive
  • None.
Negative
  • None.

CARLSBAD, Calif., Nov. 3, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

  • Guggenheim 5th Annual Inflammation, Neurology, & Immunology Conference on Tuesday, November 7, 2023
  • Stifel 2023 Healthcare Conference on Tuesday, November 14, 2023
  • Piper Sandler 35th Annual Healthcare Conference 2023 on Tuesday, November 28, 2023
  • BMO 2023 Growth & ESG Conference on Monday, December 4, 2023

A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionispharma.com/events-and-presentations/upcoming-events. Replays will be available on the Ionis website within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals
For more than 30 years, Ionis has been a leader in RNA-targeted therapy, pioneering new markets and changing standards of care. Ionis currently has four marketed medicines and a promising late-stage pipeline highlighted by cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision to become the leader in genetic medicine, utilizing a multi-platform approach to discover, develop and deliver life-transforming therapies.

To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301976539.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

Which investor conferences will Ionis Pharmaceuticals participate in?

Ionis Pharmaceuticals will participate in the Guggenheim 5th Annual Inflammation, Neurology, & Immunology Conference, Stifel 2023 Healthcare Conference, Piper Sandler 35th Annual Healthcare Conference 2023, and BMO 2023 Growth & ESG Conference.

When will the investor conferences take place?

The conferences will take place on November 7, November 14, November 28, and December 4, 2023.

Where can I access the live webcast of the presentations?

The live webcast of the presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionispharma.com/events-and-presentations/upcoming-events.

Will replays of the presentations be available?

Yes, replays of the presentations will be available on the Ionis website within 48 hours.

For how long will the replays be archived?

The replays will be archived for a limited time on the Ionis website.

Ionis Pharmaceuticals, Inc.

NASDAQ:IONS

IONS Rankings

IONS Latest News

IONS Stock Data

5.19B
145.97M
0.78%
99.5%
6.26%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
CARLSBAD